(1 - 41 von 91
)
UCB to provide additional information to the U.S. FDA ...UCB-USA.com
www.ucb-usa.com
Antje Witte, Investor Relations, UCB T + , . Isabelle Ghellynck, Investor Relations, UCB T+ , isabelle.ghellynck ... Antje Witte, Investor Relations, UCB T + , . Isabelle Ghellynck, Investor Relations, UCB T+ , isabelle.ghellynck ...
UCB: Acquisition of own sharesFirstWord Pharma
firstwordpharma.com
— Acquisition of own shares · For further information, contact UCB: · Investor Relations Antje Witte · Corporate Communications Laurent Schots · About — Acquisition of own shares · For further information, contact UCB: · Investor Relations Antje Witte · Corporate Communications Laurent Schots · About ...
UCB Announcements | UCB: Information Investegatewww.investegate.co.uk › gnw › information-rega...
www.investegate.co.uk
... Antje Witte, Vice-President Corporate Communications & Investor Relations T + , About UCB UCB, ...
CIMZIA® (certolizumab pegol) Label Change Marks Important Advance for...
www.ots.at
France Nivelle, Antje Witte, Andrea Levin Christopher, Global Communications, UCB Investor Relations, UCB ImmunologyCommunications, ...
sortiert nach Relevanz / Datum